Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT04599140	TitleSX-682 y nivolumab para el tratamiento del cáncer colorrectal metastásico o irresecable con mutación del RAS, el ensayo STOPTRAFFIC-1	Fase Fase 1	Date Added 2020-10-22	Ubicación Texas, United States	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas CXCR1/2 Inhibitor SX-682, Nivolumab	Etiquetas MSS/ MMRp
NCT ID NCT04724239	TitleA Study of Sintilimab and Chidamide in Combination With or Without IBI305 in Standard Treatment Failure of Advanced or Metastatic pMMR/MSS Colorectal Carcinoma	Fase Fase 2	Date Added 2021-01-26	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Activo, no recluta	Drogas chidamide, IBI305, Sintilimab	Etiquetas MSS/ MMRp
NCT ID NCT06566755	TitleCadonilimab (AK104) Combined With Chemotherapy and Bevacizumab as First-line Treatment for RAS Mutated or Right Sided-metastatic MSS Colorectal Cancer	Fase Fase 3	Date Added 2024-08-22	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSS/ MMRp
NCT ID NCT06589440	TitlePhase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)	Fase Fase 2	Date Added 2024-09-19	Ubicación New Jersey, United States Texas, United States Washington, United States	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Balstilimab, Botensilimab	Etiquetas MSS/ MMRp
NCT ID NCT06493760	TitleA Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients	Fase Fase 2	Date Added 2024-07-10	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT06513221	TitleA Prospective Study of MSS-type Metastatic Colorectal Cancer Receiving Multiple Lines of Standard Chemotherapy, Bevacizumab Combined With Adebrelimab	Fase	Date Added 2024-07-22	Ubicación	Prior IO Allowed No	CRC-directed Sí	Status	Drogas	Etiquetas MSS/ MMRp
NCT ID NCT06788171	TitlePULSAR Combined With PD-1 Ab and Chemotherapy Plus Bev. for CRLM	Fase Fase 2	Date Added 2025-03-25	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Aún no se ha contratado	Drogas	Etiquetas MSS/ MMRp
NCT ID NCT06794086	TitleSBRT + PD-1 Monoclonal Antibody in Unresectable Colorectal Liver Metastases	Fase Fase 3	Date Added 2025-01-27	Ubicación China	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSS/ MMRp
NCT ID NCT06792695	TitleA Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer	Fase Fase 2	Date Added 2025-03-25	Ubicación Arizona, United States California, United States District of Columbia, United States Illinois, United States Maryland, United States Massachusetts, United States Minnesota, United States New York, United States Ohio, United States Texas, United States Australia Canadá China Francia Alemania Italia Corea, República de España Taiwán Reino Unido	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas	Etiquetas MSS/ MMRp
NCT ID NCT06801665	TitleFMT+ QL1706+bevacizumab+ XELOX As First-line Treatment for Advanced MSS-type Colon Cancer with Liver Metastasis	Fase Fase 2	Date Added 2025-01-30	Ubicación	Prior IO Allowed No	CRC-directed Sí	Status Aún no se ha contratado	Drogas	Etiquetas MSS/ MMRp

Showing 151 to 160 of 299 entries